Pieter T. de Boer

Retrospective public health impact of a quadrivalent influenza vaccine in the United States

Pascal Crépey, Pieter T. de Boer, Maarten J. Postma et al. · Influenza and Other Respiratory Viruses · 2015 · 54 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Occupation- and age-associated risk of SARS-CoV-2 test positivity, the Netherlands, June to October 2020

Brechje de Gier, Priscila de Oliveira Bressane Lima, Rolina D. van Gaalen et al. · Eurosurveillance · 2020 · 51 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +17

Persistence with osteoporosis medication among newly-treated osteoporotic patients

Job F. M. van Boven, Pieter T. de Boer, Maarten J. Postma et al. · Journal of Bone and Mineral Metabolism · 2013 · 50 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +12

Burden of surgical site infections in the Netherlands: cost analyses and disability-adjusted life years

M.B.G. Koek, Tjallie van der Kooi, F.C.A. Stigter et al. · Journal of Hospital Infection · 2019 · 48 citations

Pharmacy, Pharmacoeconomics, Surgery +16

Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands

Pieter T. de Boer, Lisa Nagy, F Christiaan K Dolk et al. · Value in Health · 2020 · 39 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17